MICHAEL JAMES OVERMAN to Receptor, ErbB-2
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Receptor, ErbB-2.
Connection Strength
0.433
-
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway. Clin Cancer Res. 2019 01 15; 25(2):641-651.
Score: 0.312
-
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer. J Natl Cancer Inst. 2018 12 01; 110(12):1409-1417.
Score: 0.079
-
Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer. 2010 Jan 05; 102(1):144-50.
Score: 0.042